http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0649185-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc6220b93fae4be14ada49e4ecc1860b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G63-82
filingDate 1993-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce96c7aed0b48428b1b0d1239697c4f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f127e5a908b0fc1d1b305bb7f2f01a1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caf825557013f6a79ac8f5139b2985a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a49bf43b139136c95e4999efb295b3
publicationDate 1994-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0649185-A
titleOfInvention New polymer
abstract (57) [Summary] [Constitution] The present invention is useful as a polymer for bioabsorbable pharmaceutical preparations, has a weight average molecular weight of about 5,000 or more and 30,000 or less, contains no catalyst, and is a dispersion obtained by gel permeation chromatography. About 50-95% by weight of lactic acid with a degree of about 1.5-2 And a lactic acid / glycolic acid copolymer comprising about 50 to 5% by weight of glycolic acid. [Effect] Since the copolymer of the present invention undergoes polycondensation without using any polymerization catalyst, the obtained copolymer does not contain any polymerization catalyst, and thus can be mainly used as a pharmaceutical preparation base. For example, steroid hormones, peptide hormones, or carcinostatic agents, etc. are contained, and they can be advantageously used as implantable or microcapsule sustained-release preparations, or fine particles containing carcinostatic agents are prepared and embolization therapeutic agents.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7153523-B2
priorityDate 1984-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6128521-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5645920-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4011312-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID111433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415814663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451536570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16741157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415742045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417109324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407364031

Total number of triples: 31.